| Financial Year |
March 31 2023 |
| Monetary Funds |
1,009,070,878.97 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
471,585,110.70 |
| Advances to Suppliers |
149,455,849.17 |
| Other Receivables |
109,064,473.04 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
507,370,159.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
11,293,298.94 |
| Total Current Assets |
2,257,839,770.05 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
340,179.82 |
| Investment Properties |
-- |
| Fixed Assetes |
3,458,200.93 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
2,352,696.90 |
| R&D expenses |
-- |
| Goodwill |
216,453,191.49 |
| Long-Term Deferred and Prepaid Expenses |
1,866,542.94 |
| Deferred Income Tax Assets |
16,862,342.34 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
256,557,450.43 |
| Total Assets |
2,514,397,220.48 |
| Short-Term Loans |
150,169,583.36 |
| Trading Financial liabilities |
-- |
| Notes Payable |
594,605,640.25 |
| Accounts Payable |
44,307,829.24 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
28,095,662.70 |
| Taxes Payable |
65,888,480.68 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
81,760,632.11 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,535,508.85 |
| Other Current Liabilities |
5,854,003.03 |
| Sub-Total of Current Liabilities |
978,915,387.08 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
358,446.32 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,154,202.44 |
| Total Liabilities |
981,069,589.52 |
| Paid-In Capital(Or Share Stock) |
719,989,783.00 |
| Capital Surplus |
1,296,241,823.56 |
| Surplus Reserve |
132,821,361.13 |
| LESS:Treasury Stock |
42,271,888.03 |
| Undistributed Profits |
-584,910,383.02 |
| Minority Stockholder's Interest |
11,456,934.32 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,521,870,696.64 |
| Owner's Equity（Stockholder's Equity） |
1,533,327,630.96 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,514,397,220.48 |
